8-K//Current report
Revance Therapeutics, Inc. 8-K
Accession 0001479290-22-000052
CIK 0001479290operating
Filed
Apr 20, 8:00 PM ET
Accepted
Apr 21, 4:11 PM ET
Size
168.8 KB
Accession
0001479290-22-000052
Documents
- 8-Krvnc-20220421.htmPrimary
8-K
- EX-101.SCHrvnc-20220421.xsd
XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT
- EX-101.LABrvnc-20220421_lab.xml
XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT
- EX-101.PRErvnc-20220421_pre.xml
XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT
- XMLR1.htm
IDEA: XBRL DOCUMENT
- XMLrvnc-20220421_htm.xml
IDEA: XBRL DOCUMENT
- EXCELFinancial_Report.xlsx
IDEA: XBRL DOCUMENT
- XMLShow.js
IDEA: XBRL DOCUMENT
- XMLreport.css
IDEA: XBRL DOCUMENT
- XMLFilingSummary.xml
IDEA: XBRL DOCUMENT
- JSONMetaLinks.json
IDEA: XBRL DOCUMENT
- ZIP0001479290-22-000052-xbrl.zip
IDEA: XBRL DOCUMENT
Issuer
Revance Therapeutics, Inc.
CIK 0001479290
Entity typeoperating
IncorporatedDE
Related Parties
1- filerCIK 0001479290
Filing Metadata
- Form type
- 8-K
- Filed
- Apr 20, 8:00 PM ET
- Accepted
- Apr 21, 4:11 PM ET
- Size
- 168.8 KB